Conference Room Management Software Market Size Development Data Analysis And Growth Forecast 2022 To 2028 Aventri Robin Skedda Condeco Ems Software Teem Joan Yarooms Pronestor Boomset Ha

Posted on May 23, 2022July 17, 2025 by

Conference Room Management Software Market Size, Development Data, Analysis and Growth Forecast 2022 to 2028 -Aventri, Robin, Skedda, Condeco, EMS Software, Teem, Joan, YArooms, Pronestor, Boomset, Hamilton Apps, Roomzilla

By Mallory J. Vaughan on May 23, 2022 Conference room

New Jersey, United States – The Conference Room Management Software Market report includes the upcoming challenges and opportunities in the market. It ensures a strengthened market position and a growing product portfolio by providing all the important details related to the market growth. It reveals some of the key insights and focuses on the impact of the COVID-19 crisis on different sectors of the economy. Identifying key business areas is the single most important factor in improving those areas and generating greater profits. This living market research provides an in-depth understanding of how new product offerings can fit into the market. It acts as the best guide and plays the leading role in almost all phases of the business cycle. It also becomes easy to effectively target customers to easily launch new products. This Conference Room Management Software market reports another key focus is to provide manufacturing solutions at all provincial and global levels.

Some of the major companies influencing this market include:

Aventri, Robin, Skedda, Condeco, EMS Software, Teem, Joan, YArooms, Pronestor, Boomset, Hamilton Apps, Roomzilla

A comprehensive overview of market conditions and various business-related elements is covered in this Conference Room Management Software market research report. It enables business actors to reach target groups and provides all important details about customers and competitors. Quantitative research methods are used to conduct this market research to provide accurate market data and problem solving. The Conference Room Management Software Market report helps to identify major regions such as Asia-Pacific, North America, Europe, Middle East, Africa and Latin America where new players and merchants can develop their activities. Moreover, it performs in-depth analysis and provides market size, market dynamics, and market share.

Get the Sample PDF Copy (Including Full TOC, Graphs and Tables) of this [email protected] https://www.maccuracyreports.com/report-sample/194465

Various factors are responsible for the growth trajectory of the market, which are studied extensively in the report. Additionally, the report lists restraints that threaten the global conference room management software. .This report is a consolidation of primary and secondary research, which provides market size, share, dynamics and forecasts for various segments and sub-segments considering macro and micro environmental factors. It also assesses the bargaining power of suppliers and buyers, the threat of new entrants and product substitutes, and the degree of competition prevailing in the market.

ATTRIBUTES	DETAILS
ESTIMATED YEAR	2022
YEAR OF REFERENCE	2021
FORECAST YEAR	2029
HISTORICAL YEAR	2020
UNITY	Value (million USD/billion)
SECTORS COVERED	Types, applications, end users, and more.
REPORT COVER	Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE	Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Types of Conference Room Management Software Market:

Applications of Conference Room Management Software Market:

SMEs, Large Companies

The report studies the key segments of the global Conference Room Management Software industry, their growth over the past few years, the profiles and market size of the individual segments, and provides a detailed overview of the profiles of the various segments. The report also presents the key products and various other products of the global Conference Room Management Software industry along with its market size and growth over the study period. The key drivers of demand for the products and services of the global Conference Room Management Software industry are outlined in the report. The Conference Room Management Software report details some major success factors and risk factors for investing in certain segments.

The report provides information about the following pointers:

Market penetration: Comprehensive data on product portfolios of leading Conference Room Management Software Market players.

Product Development/Innovation: Detailed information on upcoming technologies, R&D; activities and product launches in the market.

Competitive evaluation: An in-depth analysis of the market strategies of major companies in the market, along with their geographical and business segments.

Market development: Information on developing markets in full. This study examines the market in several geographies for different segments.

Market Diversification: Detailed data on new products, untapped geographies, recent advancements, and investment opportunities in the Conference Room Management Software market.

Get Up To 30% Off The First Purchase Of This Report @ https://www.maccuracyreports.com/check-discount/194465

The cost analysis of the Global Conference Room Management Software Market has been done while considering manufacturing expense, labor cost, and raw material along with their market concentration rate, suppliers and the price trend. Other factors such as supply chain, downstream buyers, and sourcing strategy have been assessed to provide a comprehensive and in-depth view of the market. Buyers of the report will also be exposed to market positioning study with factors such as target customer, brand strategy, and pricing strategy taken into consideration.

Key questions covered in this report?

A comprehensive overview of different geographical distributions and common product categories in the Conference Room Management Software market.
When you have information about cost of production, cost of products and cost of production for the coming years, you can repair the developing databases for your industry.
In-depth burglary analysis for new companies seeking to enter the conference room management software market.
How do top and mid-tier companies make money in the market?
Conduct an in-depth study on the general condition of the Conference Room Management Software market to aid in the selection of product launches and reviews.

Contents

Global Conference Room Management Software Market Research Report 2022-2029

Chapter 1 Overview of Conference Room Management Software Market

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Conference Room Management Software Market Forecast

Buy exclusively [email protected]: https://www.maccuracyreports.com/checkout/194465

If you have any special requirements, please let us know and we will offer you the report you want.

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Villarreal Snatch Europa Conference League Berth With Key Win At Barcelona

Posted on May 22, 2022July 17, 2025 by

Villarreal snatch Europa Conference League berth with key win at Barcelona

By Mallory J. Vaughan on May 22, 2022 Conference league

Villarreal sealed a place on the final day of the 2022/23 Europa Conference League after claiming a 2-0 win at Barcelona.

Unai Emery’s side secured their first league victory at Camp Nou since 2008, to edge past Athletic Club in the hunt for 7th place, and the last remaining European spot in La Liga this season.

Xavi’s hosts created the better chances early on in Catalonia, but it was Villarreal who found the vital breakthrough just before the break as Alfonso Pedraza tapped in Dani Parejo’s pass.

Villarreal leads against Barcelona! 🟡

Pedraza punishes Dani Alves for drifting out of position 😬 pic.twitter.com/Ac6Xi018wY

— Premier Sports (@PremierSportsTV) May 22, 2022

That goal changed the momentum after the break, with Villarreal posing a constant threat on the counterattack, as Moi Gomez pounced on Adama Traore’s error to score a second goal on the night.

Moi Gómez doubles Villarreal’s lead thanks to an assist from… Adama Traoré! 😬

What was the Barcelona man thinking 🤷 pic.twitter.com/vluiwYQ4vK

— Premier Sports (@PremierSportsTV) May 22, 2022

Despite the result, Barcelona still end the campaign in second place, with a Champions League spot secured ahead of the final day of 2021/22.

Images via Getty Images

Source link

About Author

Mallory J. Vaughan

Comments are closed.

The Europa Conference League Is Romas Champions League

Posted on May 21, 2022July 17, 2025 by

The Europa Conference League is Roma’s Champions League

By Mallory J. Vaughan on May 21, 2022 Conference league

Speculation over Kylian Mbappe’s future is finally over as he will stay at Paris Saint-Germain.

The 23-year-old was expected to join Real Madrid as a free agent, but it was confirmed on Saturday that the French striker had signed a new three-year contract. contract with PSG.

Mbappe joined Ligue 1 champions Monaco, initially on loan, in 2017 and spearheaded the capital club, although he played alongside Neymar and, from the 2021-22 season, by Lionel Messi.

PSG were desperate to keep the World Cup winner and have now gotten their wish.

Here, Stats Perform breaks down the key numbers and records behind Mbappe’s PSG career to date.

The key figures

217 – While featured in PSG’s starting XI against Metz, he has made 217 appearances so far, more than any other player since joining the club. Of those appearances, 190 were departures.

168 – Before the game against Metz, the striker scored an incredible 168 goals for PSG, 72 more than Neymar, who was second on the list since Mbappe bowed out at PSG.

77 – Before the game against Metz, he was also the best passer since joining PSG, creating 77 goals.

775 – As expected, he also topped the PSG team in shots, with 775 shots, 398 of which hit the target. Magnificent.

42 – No player has contributed to more goals in Europe’s top five leagues this season before Saturday’s game than Mbappe, who has been involved in 42.

Recordings

15 – This season, Mbappe has become the first player to score at least 15 goals and provide at least 15 assists in a single Ligue 1 campaign since Eden Hazard did so for Lille in the 2011-12 campaign.

100 – When he scored against Lyon in March 2021, Mbappé became the youngest player to score 100 Ligue 1 goals, aged 22 years and 91 days. He is also the youngest player to score a century of goals in Europe’s top five leagues of the 21st century.

2 – Mbappe is already Ligue 1’s second top scorer since the turn of the century, having netted 132 times in the competition before Saturday’s game. Only the great PSG Edinson Cavani, with 138, scored more.

1 – He hopes to become the first player to finish top scorer and the main assist provider in the same Ligue 1 season since Opta started collecting this data in 2008.

8 – Ever consistent, Mbappe had scored at least one goal and provided at least one assist in eight different Ligue 1 games this season, the highest tally of his career in the same top-flight campaign, before the last game of the 2021 -22 campaign.

3 – Mbappe is aiming to be the third player to finish top scorer in four consecutive Ligue 1 seasons, after Carlos Bianchi (four in a row with Reims and PSG) and Jean-Pierre Papin (five in a row with Marseille).

50 – It’s not just domestically that Mbappe has thrived. Since Opta collected such data, starting in the 2003-04 season, he is the fastest and youngest player to reach 50 Champions League goals, doing so in 51 appearances, at age 22 years and 352 days.

32 – At kick-off against Metz, Mbappé was at 32 goals shy of equaling Cavani’s club record of 200 for PSG.

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Uefa Europa Conference League Final Roma Vs Feyenoord See The Finalists

Posted on May 20, 2022July 17, 2025 by

UEFA Europa Conference League final, Roma vs Feyenoord: see the finalists

By Mallory J. Vaughan on May 20, 2022 Conference league

The first-ever UEFA Europa Conference League final will feature Roma and Feyenoord. Meet the teams chasing the top prize in Tirana.

Highlights: Roma 4-0 Bodø/Glimt

Can Roma win the Europa Conference League?
José Mourinho has never lost a European final, and Roma are solid overall and quick up front: essential ingredients when it comes to one-off matches.

UEFA Roma Ranking: 11

History of UEFA in Rome
How they qualified: Group C winners (W4 D1 L1 F18 A11), 2-1agg Vitesse (R16), 5-2agg Bodø/Glimt (QF), 2-1agg Leicester (SF)
last season: UEFA Europa League semi-finals (L 8-5 agg vs Man. United)
Best in UEFA Cup/Europa League: finalist (1990/91)

Group stage highlights: Bodø/Glimt 6-1 Roma

Campaign so far
After some ups (four wins) and lows in the group stage (including a 6-1 loss at Bodø/Glimt), Roma found consistency in the knockout stage, reacting well to the defeat at Bodø/Glimt in the quarter-final first leg and making the most of a passionate and jam-packed Stadio Olimpico to see Leicester in the semi-finals.

How do Roma play?
Mourinho has three at the back, two attacking wingers, strong midfielders and two dynamic players behind lone striker Tammy Abraham. Roma like to attack quickly, advancing the ball with as few touches as possible. The goal is to get Nicolò Zaniolo and Lorenzo Pellegrini into space and Abraham one-on-one with the goalkeeper.

Who is Roma’s key player?
Tammy Abraham. Replacing Edin Džeko was no easy task, but Abraham has done magnificently since leaving Chelsea. The big striker is very mobile, bonds well with his midfield teammates and takes chances when they arise. So far, nine goals in this competition tell their own story.

Who is Roma’s coach?
Jose Mourinho. With two UEFA Champions League and two UEFA Europa League/UEFA Cup victories to his name, Mourinho is aiming to become the first manager to win all three UEFA men’s club competitions. He is both a serial winner and an expert in handling pressure at the highest level.

Did you know?
Roma are the only team to have reached the semi-finals of the UEFA Champions League, UEFA Europa League and UEFA Europa Conference League.

All the goals on Feyenoord’s road to the Conference League final

Can Feyenoord win the Europa Conference League?
Feyenoord were underdogs in the semi-final against Marseille after a relatively smooth run in the earlier rounds, but were adventurous in winning the first leg and shrewd in drawing the second. They can play attacking football, defend resolutely and above all, they are not easily scared.

Feyenoord UEFA ranking: 42

Feyenoord History of UEFA
How they qualified: Group E winners (W4 D2 L0 F11 A6), 8-3agg Partizan (R16), 6-4agg Slavia Praha (QF), 3-2agg Marseille (SF)
last season: UEFA Europa League group stage (third section)
Best in UEFA Cup/Europa League: winners (1973/74, 2001/02)

Highlights: Feyenoord 3-2 Marseille

Campaign so far
Feyenoord are unbeaten in the tournament proper, with eight wins and four draws. After winning Group E six points clear of Slavia Praha and Union Berlin, they netted eight goals against Partizan in the round of 16 before scoring six more against Slavia Praha (again) in quarter-final, and three more modest ones against OM.

How does Feyenoord play?
They play a nominal 4-2-3-1 formation, with Cyriel Dessers the only designated striker, but in reality Luis Sinisterra spends most of his time just as high up the pitch. Full-backs Lutsharel Geertruida and Tyrell Malacia are still keen to overlap. While the normal modus operandi is based on possession, the long ball over the defense was used to devastating effect in the semi-final first leg against Marseille.

Who is Feyenoord’s key player?
Cyriel Desser. The striker has found the net ten times in the Europa Conference League, making him the competition’s top scorer. Quick to pick up and fast too, Dessers has shown he can deliver when it really matters.

Who is the manager of Feyenoord?
Arne’s Slot. In his first season at the helm of Rotterdam after a spell at AZ Alkmaar, Slot transformed Feyenoord into an attacking-minded team that eagerly chases the ball and then uses it to good effect. He far exceeded expectations by taking the club to the final.

Did you know?
Feyenoord won the European Cup in 1970 and the UEFA Cup in 1974 and 2002. Win the UEFA Europa Conference League and they will be the first and only team to get their hands on the current three major trophies for men’s clubs in UEFA.

Download the Europe app!

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Albania Declares Holiday For Europa Conference League Final Winnipeg Free Press

Posted on May 18, 2022July 17, 2025 by

Albania declares holiday for Europa Conference League final – Winnipeg Free Press

By Mallory J. Vaughan on May 18, 2022 Conference league

TIRANA, Albania (AP) — The Albanian government has declared a public holiday in Tirana next Wednesday when the capital hosts the Europa Conference League final between Roma and Feyenoord.

There will be a zone reserved for pedestrians as part of the measures “to organize in the most exemplary way one of the most important events that have happened in Albania”, Interior Minister Bledi Cuci said on Wednesday. .

Up to 100,000 Italian and Dutch football fans are expected in Tirana, although each team has received just 4,000 tickets for the inaugural final of Europe’s third-tier club competition.

Roma supporters celebrate at the end of a Conference League semi-final soccer match between Roma and Leicester City at the Olympic stadium in Rome on Thursday May 5, 2022. Roma won 1-0. (AP Photo/Andrew Medichini)

The capacity of the national arena is only about 20,000 people.

“We are taking all measures to make the day festive for everyone, not just the Italian and Dutch fans,” Cuci said.

UEFA chose Tirana as their hosts in December 2020, a year after the official opening of the new stadium and before any team qualified to participate in the first competition.

Feyenoord players celebrate the end of the Europa Conference League semi-final, second leg soccer match between Olympique de Marseille and Feyenoord at the Velodrome stadium in Marseille, southern France, Thursday May 5, 2022. (AP Photo/Daniel Cole)

The final is a more publicized game than many imagined in 2018 when UEFA decided to create the Europa Conference League. Its aim was to give clubs from lower-ranked countries more opportunities to remain involved in European competitions beyond December.

An even smaller stadium – the Eden Arena in Prague – is set to host the 2023 final.

Roma coach Jose Mourinho has said he is looking forward to visiting Albania for the first time.

“It’s one of the few countries in Europe I’ve never played in,” Mourinho said. “The fact that the stadium is too small for two clubs like Roma and Feyenoord is the only negative point of the match.

“But if it was a 50,000 or 70,000 seat stadium, it would still be small,” added Mourinho. “If we played at (Real Madrid’s Santiago Bernabeu stadium), it would still be small.”

Around 88% of the remaining tickets were bought by Albanian fans and Mourinho said local spectators should support Roma as the team has Albanian defender Marash Kumbulla.

“If Roma win the cup, an Albanian wins the cup, an Albanian lifts the cup in Tirana,” Mourinho said. “That should be more than enough for the Albanian people to support the Roma.”

There are concerns about violence for the game after Feyenoord fans clashed with Italian police and damaged a historic fountain near the Spanish Steps ahead of a Europa League game in Rome in 2015.

UEFA, the Albanian Football Association and law enforcement have taken precautionary measures to stage the final safely.

Around 650 stewards will be inside the stadium and 2,000 police outside.

“Countries like Albania deserve this opportunity,” Mourinho said. “I remember playing the European Super Cup between Manchester United and Real Madrid in North Macedonia (in 2017) and it was a fantastic event.

___

AP Sports Writer Andrew Dampf in Rome contributed to this report.

___

More AP soccer: https://apnews.com/hub/soccer and https://twitter.com/AP_Sports

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Albania Declare Vacation For Europa Conference League Final

Posted on May 18, 2022July 17, 2025 by

Albania declare vacation for Europa Conference League final

By Mallory J. Vaughan on May 18, 2022 Conference league

TIRANA, Albania (AP) — The Albanian government has declared a public holiday in Tirana next Wednesday when the capital hosts the Europa Conference League final between Roma and Feyenoord.

Up to 100,000 Italian and Dutch football fans are expected…

TIRANA, Albania (AP) — The Albanian government has declared a public holiday in Tirana next Wednesday when the capital hosts the Europa Conference League final between Roma and Feyenoord.

Up to 100,000 Italian and Dutch football fans are expected in Tirana, although each team has received just 4,000 tickets for the inaugural final of Europe’s third-tier club competition.

The capacity of the national arena is only about 20,000 people.

“We are taking all measures to make the day festive for everyone, not just the Italian and Dutch fans,” Cuci said.

UEFA chose Tirana as their hosts in December 2020, a year after the official opening of the new stadium and before any team qualified to participate in the first competition.

The final is a more publicized match than many imagined in 2018 when UEFA decided to create the Europa Conference League. Its aim was to give clubs from lower-ranked countries more opportunities to remain involved in European competitions beyond December.

An even smaller stadium – the Eden Arena in Prague – is set to host the 2023 final.

Roma coach Jose Mourinho has said he is looking forward to visiting Albania for the first time.

“But if it was a 50,000 or 70,000 seat stadium, it would still be small,” Mourinho added. “If we played at (Real Madrid’s Santiago Bernabeu stadium), it would still be small.”

Around 88% of the remaining tickets were bought by Albanian fans and Mourinho said local spectators should support Roma as the team has Albanian defender Marash Kumbulla.

“If Roma win the cup, an Albanian wins the cup, an Albanian lifts the cup in Tirana,” Mourinho said. “That should be more than enough for the Albanian people to support the Roma.”

There are concerns about violence for the game after Feyenoord fans clashed with Italian police and damaged a historic fountain near the Spanish Steps ahead of a Europa League game in Rome in 2015.

UEFA, the Albanian Football Federation and law enforcement have taken precautionary measures to stage the final safely.

Around 650 stewards will be inside the stadium and 2,000 police outside.

___

AP Sports Writer Andrew Dampf in Rome contributed to this report.

___

More AP soccer: https://apnews.com/hub/soccer and https://twitter.com/AP_Sports

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Biolargo Q1 2022 Results Webcast And Conference Call On Thursday May 19 2022

Posted on May 17, 2022July 17, 2025 by

BioLargo Q1 2022 Results Webcast and Conference Call on Thursday, May 19, 2022

By Mallory J. Vaughan on May 17, 2022 Conference call

WESTMINSTER, CA/ACCESSWIRE/May 17, 2022/ BioLargo, Inc. (OTCQB: BLGO), a clean technology developer and full-service environmental engineering firm, has announced that it will host a webcast and conference call for investors on Thursday, May 19, 2022 at 1:00 p.m. Pacific / 4:00 a.m. EST. The event, which will be open to the public, will aim to review the company’s financial results for the three months ended March 31, 2022, discuss recent milestones and upcoming plans, and conduct a questions answers.

To listen to a live broadcast, go to the site below at least 15 minutes before the scheduled start time to register and download any necessary audio video software.

To participate in the live webcast and conference call:

To watch or listen to a webcast or conference call replay:

Web Replay Expiration:	Friday, May 19, 2023
Meeting Replay Timeout:	Thursday 02 June 2022
National teleconference replay:	877-481-4010
Replay International teleconference:	919-882-2331
Replay password:	45648

The webcast replay and accompanying presentation materials will be made available in the Investor Relations section of BioLargo’s website at www.biolargo.com/investor-relations.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB: BLGO) invents, develops and markets innovative cleantech technologies, including PFAS contamination, advanced water and wastewater treatment, odor and industrial VOCs, air quality control and infection control. With over 13 years of extensive R&D;, BioLargo holds a wide array of issued patents, maintains a robust product portfolio, and provides full-service environmental engineering. Our approach is to invent or acquire new technologies and develop them to maturity via our operating subsidiaries. We have developed a number of key distribution partnerships to support the reach of our products and services and maximize their market potential. With a focus on collaborations with academic, municipal and commercial organizations and associations, BioLargo has a proven track record with over 80 grants awarded and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, forming a strategic joint venture and/or selling intellectual property. See our website at www.BioLargo.com.

Contact information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, those regarding BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; expected income; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from future results expressed or implied by the forward-looking statements. Risks and uncertainties include, but are not limited to: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition and stock price; the effect of regional economic conditions on the Company’s business, including effects on consumer and business purchasing decisions; the Company’s ability to compete in highly competitive markets subject to rapid technological change; the Company’s ability to manage frequent product and service introductions and transitions, including delivering to market and driving customer demand for new products, services and technology innovations on a timely basis; the Company’s dependence on the performance of distributors of the Company’s products. Further information about these risks and other potential factors that could affect the Company’s business and financial results are included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the most recent periodic reports filed by the Company on Forms 10-K and 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

THE SOURCE: BioLargo, Inc.

See the source version on accesswire.com:
https://www.accesswire.com/701765/BioLargo-Q1-2022-Earnings-Results-Webcast-and-Conference-Call-on-Thursday-May-19-2022–400-PM-Eastern-Time

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Windtree Announces Conference Call To Present Data From Its Positive Phase 2 Seismic Study Of Istaroxime In Early Cardiogenic Shock

Posted on May 17, 2022July 17, 2025 by

Windtree Announces Conference Call to Present Data from its Positive Phase 2 SEISMiC Study of Istaroxime in Early Cardiogenic Shock

By Mallory J. Vaughan on May 17, 2022 Conference call

The call will take place on Monday, May 23 at 4:30 p.m. EDT following the breaking news presentation at the European Society of Cardiology meeting on heart failure

WARRINGTON, Pa., May 16, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that management will host a conference call and webcast to discuss its Phase 2 study of istaroxime in patients with early cardiogenic shock following the presentation of data at the European Society of Cardiology meeting on heart failure in Madrid, Spain on May 23, 2022.

The company had previously announced a positive result from the trial and explained that further details were under embargo due to the acceptance of the late presentation at the heart failure meeting. On the call, management plans to present additional study results, including secondary measures associated with changes in blood pressure, systolic and diastolic cardiac function, renal profile, safety and tolerability. . The next stages of development and the broader prospects of the Company will also be presented.

Shareholders and other interested parties may participate in the conference call by dialing (877) 423-9813 (in the United States) or (201) 689-8573 (outside the United States) and entering the passcode. access 13729819. The call will also be webcast live and be available by clicking on the link HERE. A link to the webcast can also be found on the Events page of the Society’s website: https://ir.windtreetx.com/events.

A replay of the call will be available on the Company’s website for 90 days at https://ir.windtreetx.com/events.

About Cardiogenic Shock
Cardiogenic shock is a serious condition that occurs when the heart fails significantly and cannot pump enough blood and oxygen to the brain, kidneys and other vital organs. Mortality rates are significant and, depending on severity, range from 7% to 40% in the United States. a dysfunction or even an increase in mortality which limits their usefulness and positions them as “rescue drugs” for serious cases. Market research found that 99% of 100 US-based clinical cardiologists surveyed who treat cardiogenic shock patients responded that new drug innovations to treat SCAI Class B cardiogenic shock patients are highly needed. The total market value of cardiogenic shock worldwide is estimated at $1.25 billion, calculated using hospital claims of cardiogenic shock patients in the United States and global prevalence data multiplied by various assumed regional prices of the treatment medicated.

About Istaroxime
Istaroxime is a first class dual mechanism therapy designed to improve both systolic and diastolic heart function. Istaroxime is a positive inotropic agent that increases myocardial contractility through inhibition of Na+/K+- ATPase with a complementary mechanism that facilitates myocardial relaxation through activation of the calcium pump SERCA2a on the sarcoplasmic reticulum, improving reuptake of calcium from the cytoplasm. Data from several phase 2 studies in patients with acute heart failure (AHF) demonstrate that intravenously administered istaroxime significantly improves cardiac function and blood pressure without causing an increase in heart rate or arrhythmias.

About Windtree Therapeutics
Windtree Therapeutics, Inc. is advancing several late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in crisis. Using novel scientific and clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds capable of activating SERCA2a, with the lead candidate, istaroxime, being developed as a first-in-class treatment for acute heart failure and early cardiogenic shock. Windtree’s heart failure platform also includes follow-on oral preclinical SERCA2a activator assets. In pulmonary care, Windtree focused on facilitating clinical development transfer of AEROSURF^®, to its licensee in Asia, Lee’s HK. Windtree is also evaluating surfactant KL4 for the treatment of acute respiratory distress syndrome in COVID-19 patients. Windtree’s portfolio includes rostafuroxin, a new precision drug targeting hypertensive patients with certain genetic profiles.

Forward-looking statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may, in certain circumstances, use terms such as “predicted”, “believes”, “potential”, “proposed”, ” continues”, “estimates”, “anticipates”, “expects”, “plans”, “intends”, “may”, “could”, “could”, “will”, “should” or other words that reflect the uncertainty of future events or results to identify such forward-looking statements.These statements are based on information available to the Company as of the date of this press release and are subject to numerous factors, risks and uncertainties that may cause actual events or results to differ materially from the Company’s current expectations Examples of such risks and uncertainties include: risks and uncertainties associated with the continued economic and social consequences of the VOC pandemic ID-19, including any adverse impact on the Company’s clinical trials, clinical trial delays or supply chain disruptions; the success and progress of clinical development programs for istaroxime, surfactant KL4 and the Company’s other product candidates; the impacts of political unrest, including resulting geopolitical tensions, including the escalation of the conflict between Russia and Ukraine and any additional sanctions, export controls or other restrictive measures that may be imposed by the United States and/or other countries and which could have an adverse impact on the Company’s operations, including by disrupting the supply chain or access to potential international clinical trial sites, and by disruption, instability and volatility in global markets, which could adversely impact the Company’s ability to access capital markets; the Company’s ability to obtain significant additional capital as needed; the Company’s ability to access the debt or equity markets; the Company’s ability to manage costs and execute its operating plans and budgets; the results, cost and timing of the Company’s clinical development programs, including delays in such clinical trials related to registration or site initiation; risks related to technology transfers to subcontractors and manufacturing development activities; delays experienced by the Company, contractors or suppliers in manufacturing drug products, drug substances, aerosol delivery systems (ADS) and other materials in a timely manner and in sufficient quantities; risks related to stringent regulatory requirements, including that: (i) the FDA or other regulatory authorities may disagree with the Company on issues raised during regulatory reviews, may require significant additional activities, or may not accept or withhold or delay consideration of applications, or may not approve or limit the approval of the Company’s product candidates, and (ii) changes in the national or international political and regulatory environment may make more difficult to obtain regulatory approvals and the risks associated with the Company’s efforts to maintain and protect patents and licenses related to its product candidates; the risks that the Company may never realize the value of its intangible assets and may incur future impairment charges; risks relating to the size and growth potential of markets for the Company’s product candidates, and the Company’s ability to serve such markets; the Company’s ability to develop its sales and marketing capabilities, alone or with potential future employees; and the rate and degree of market acceptance of the Company’s product candidates, if approved. These and other risks are described in the Company’s periodic reports, including Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, filed or furnished to the Securities and Exchange Commission and available at www.sec.gov. Any forward-looking statements the Company makes in this press release speak only as of the date of this press release. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Contact information:
Monique Kosse
LifeSci Advisors
212.915.3820 or [email protected]

Media contact:
Andrew Mielach
LifeSci Communications
646.876.5868 or [email protected]

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Cf Montreal Beats Charlotte 2 0 To Top Eastern Conference Table

Posted on May 15, 2022July 17, 2025 by

CF Montreal beats Charlotte 2-0 to top Eastern Conference table

By Mallory J. Vaughan on May 15, 2022 Conference table

After Saturday’s 2-0 win over Charlotte FC, CF Montreal top the Eastern Conference standings.

Major League Soccer’s Canadian outfit ended Charlotte FC’s four-game winning streak and extended their own run to eight games unbeaten as goals from Alistair Johnston and Đorđe Mihailović made the difference.

Montreal may have had a tough run in 2020 and 2021, ending both seasons in the mid-to-low ratings, but Wilfried Nancy could guide his team to playoff glory this year.

“I’m really happy with what the guys did tonight,” said Nancy. “It was not easy on an artificial pitch and in a stadium with a great atmosphere. We faced a good team with some interesting tactics. I’m happy because this clean sheet is good for the team.

“Today we continued to do good things. We’re on a good streak and the credit goes to the players. There’s been a boost in confidence since last year and the players like to execute the game plans .

Đorđe Mihailović pulled off another great effort for Montreal, becoming a key figure for Wilfried Nancy. The midfielder’s goal marked his sixth of the season and his second consecutive goalscoring performance, as he finds his groove in his sixth year in MLS.

“As a football player you want to play in these kinds of games even if it’s an away game,” Mihailovic said.

“When the crowd is there, 30,000 people in the stands, it also gives us energy. We haven’t really changed too many things. There have been some adjustments in our form, but we approach every game from the same way we did, with the same mentality. The things that have changed, we don’t want to change that just because we’re playing outside in front of a group of people. I’ve always said that’s was a game of ups and downs. The season will go up and down, and it feels good to feel that right now. But we can’t go too high.

Montreal may be in the lead, but the Philadelphia Union and Orlando City aren’t far behind. All three teams are currently on 20 points, with Team Canada holding the advantage with a positive goal difference of 19.

The team will be back in the league on Saturday against FC Cincinnati at Stade Saputo to try to keep the helm.

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Invitation To The Conference Call Regarding The Interim Report Of Promore Pharma For The First Quarter Of 2022

Posted on May 13, 2022July 17, 2025 by

Invitation to the conference call regarding the interim report of Promore Pharma for the first quarter of 2022

By Mallory J. Vaughan on May 13, 2022 Conference call

STOCKHOLM, SWEDEN/ACCESSWIRE/May 13, 2022/ Promote Pharma (STO:PROMO)(FRA:8T0)

STOCKHOLM, May 13, 2022 – Promore Pharma AB (publ) publishes its interim report for the first quarter of 2022 on May 17, 2022.

On the same day, the company will host a webcast conference call at 4:00 p.m. CET, with Chairman and CEO Jonas Ekblom and Chief Financial Officer Erik Magnusson, where an update for the quarter and upcoming business. After the presentation, there will be a Q&A; session. The conference call will be conducted in English and will be accessible via computer, tablet or phone.

The number of participants is limited, please register in advance for the conference on the following link:

https://attendee.gotowebinar.com/register/4045498425908535564

The conference call will be recorded and made available on the company’s website after the call, and on the Västra Hamnen Corporate Finance Youtube channel.

About Promore Pharma

Promore Pharma is a biopharmaceutical company developing drug candidates for the bioactive treatment of wounds. Today, the company has two drug candidates in advanced clinical development, based on endogenous peptides, and therefore endowed with a strong safety profile. Both of these products are intended for the treatment of chronic wounds and the prevention of scarring of the skin and other tissues. The company is listed on the Nasdaq First North Growth Market.

For more information, please contact

Jonas Ekblom, CEO
Call: [+46] 736 777 540
Email: [email protected]

Erik Magnusson, Chief Financial Officer
Call: [+46] 708 565 245
Email: [email protected]

Promore Pharmas Certified Advisor is Erik Penser Bank
Such : [+46] 8-463 83 00
Email: [email protected]

Attachments

Invitation to the conference call regarding the interim report of Promore Pharma for the first quarter of 2022

THE SOURCE: Promote Pharma

See the source version on accesswire.com:

https://www.accesswire.com/701250/Invitation-to-Conference-Call-Regarding-Promore-Pharmas-Interim-Report-for-the-First-Quarter-2022

Source link

About Author

Mallory J. Vaughan

Comments are closed.

Related posts:

About Author

Related posts:

About Author

Related posts:

About Author

Related posts:

About Author

Related posts:

About Author

Related posts:

About Author

Related posts:

About Author

Related posts:

About Author

Related posts:

About Author

Related posts:

About Author